The FDA approved the first oral PCSK9 inhibitor in July 2026. Here is what the approval, trial results, safety findings, and treatment context mean.
View More FDA Approves the First Oral PCSK9 Inhibitor: What the New Cholesterol Option MeansCategory: News
LevelsRx says it now serves 49 states as GLP-1 telehealth expands nationwide (Louisiana excluded)
Company says access is now available in most of the U.S., but state-by-state rules still shape how telehealth care works Not medical advice. This news…
View More LevelsRx says it now serves 49 states as GLP-1 telehealth expands nationwide (Louisiana excluded)Semaglutide Shows Promise in Reducing Alzheimer’s Risk, Study Finds
Research highlights potential benefits of diabetes drug for brain health A recent study has revealed promising results for semaglutide, the active ingredient in popular diabetes…
View More Semaglutide Shows Promise in Reducing Alzheimer’s Risk, Study FindsHerbalife Sets New Guinness World Record with Global Fitness Event
In a groundbreaking event that brought the world together through fitness, Herbalife Nutrition shattered a Guinness World Record by organizing the largest high-intensity interval training…
View More Herbalife Sets New Guinness World Record with Global Fitness EventAdaptogens and Medicinal Mushrooms Lead the 2024 Supplement Revolution
In 2024, the wellness market is witnessing a dramatic rise in demand for adaptogenic herbs and medicinal mushrooms, solidifying their place as essential components in…
View More Adaptogens and Medicinal Mushrooms Lead the 2024 Supplement Revolution